Navigation Links
110XiIIIPlus

Products110XiIIIPlus
Company Zebra Technologies Corporation
Item 110XiIIIPlus
Features 
  • RFID Ready
  • Handles everything from paper to specialty label/tag stocks
  • Satisfies high-volume label requirements
  • Offers a wide range of connectivity solutions
Description The entry-level printer in the High Performance line, Zebra's 110XiIIIPlus is a true 4 inch (102 mm) performance printer. This hardworking printer is the one to call on for heavy-duty, industrial operations. The 110XiIIIPlus printer is available with either 4.09 inch (104 mm) or 3.2 inch (81 mm) widths. Choose the resolution that best meets your needs, either 200, 300, or 600 dpi (8, 12, or 23.5 dots per mm). When choosing resolution, note that 600 dpi (23.5 dots per mm) is only available with 3.2 inch (81 mm) width and 4 inch (102 mm) per second speed
Info Zebra Technologies Corporation
Customer Service: (866) 230-9494
Web site: http://www.zebra.com/id/zebra/na/en/index.html

Related medicine products :

1. Reliance 6200 Patient Chair
2. Reliance 6200LFC Patient Chair
3. Luneau Patient Chair
4. MAC-150E Patient Chair
5. SDS Patient Recall
6. Moss Miami 4.0 (Small Stature Patients)
7. Diabetes Partner PC (Patient Software)
8. MediSoft Patient Accounting Software New Version 9
9. Practice Partner Patient Records
10. 3M™ Steri-Drape™ Patient Isolation Drapes
11. Patient Isolation Drape
Other Medicine News:Health News:New Insights Show Ginseng Fights Inflammation 2Health News:Karolinska Institutet Awards Honorary Degree to Feinstein Institute CEO Kevin J. Tracey, MD 2Health News:BUSM researchers find gram-negative rods in two Philippine neonatal intensive care units 2Health News:Major Physician Group Issues Statement in Support of Physician/Industry Relationships 2Health News:Major Physician Group Issues Statement in Support of Physician/Industry Relationships 3Health News:BioVex To Announce Updated Survival Data From a Phase II Clinical Study of OncoVEX GM-CSF in Metastatic Melanoma at The 2009 American Society of Clinical Oncology Meeting 2Health News:BioVex To Announce Updated Survival Data From a Phase II Clinical Study of OncoVEX GM-CSF in Metastatic Melanoma at The 2009 American Society of Clinical Oncology Meeting 3Health News:BioVex To Announce Updated Survival Data From a Phase II Clinical Study of OncoVEX GM-CSF in Metastatic Melanoma at The 2009 American Society of Clinical Oncology Meeting 4